Masimo Corporation (MASI) News

Masimo Corporation (MASI): $273.11

-1.34 (-0.49%)

POWR Rating

Component Grades













Filter MASI News Items

MASI News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

MASI News Highlights

  • For MASI, its 30 day story count is now at 52.
  • Over the past 25 days, the trend for MASI's stories per day has been choppy and unclear. It has oscillated between 1 and 10.
  • ORI, CE and BDX are the most mentioned tickers in articles about MASI.

Latest MASI News From Around the Web

Below are the latest news stories about Masimo Corp that investors may wish to consider to help them evaluate MASI as an investment opportunity.

Cybersecurity Gains Prominence in MedTech: 3 Stocks to Focus on

Technology-based healthcare stocks like Henry Schein (HSIC), Veeva Systems (VEEV) and BD (BDX) are expected to continue their rally over the next few months.

Yahoo | September 17, 2021

Masimo (MASI) Launches SuperSensor, Boosts Product Profile

Masimo's (MASI) launch of SuperSensor can help clinicians to continuously monitor patients through one comprehensive, convenient, noninvasive fingertip solution.

Yahoo | September 14, 2021

Masimo Launches Single-patient-use rainbow® SuperSensor

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo announces the CE marking & European launch of the single-patient-use rainbow® SuperSensor, with 12 noninvasive parameters on a single sensor.

Business Wire | September 13, 2021

Masimo Launches Single-patient-use rainbow SuperSensor

One Patient, One Sensor, 12 Parameters: Breakthrough Technology Offers Advanced Physiological Insight in One Comprehensive, Convenient, Noninvasive Fingertip Solution Masimo (NASDAQ: MASI) announc

FinanzNachrichten | September 13, 2021

Masimo Launches Single-patient-use rainbow® SuperSensor™

NEUCHATEL, Switzerland, September 13, 2021--Masimo announces the CE marking & European launch of the single-patient-use rainbow® SuperSensor™, with 12 noninvasive parameters on a single sensor.

Yahoo | September 13, 2021

Masimo to Present in Morgan Stanley 19th Annual Global Healthcare Conference

IRVINE, Calif., September 08, 2021--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Morgan Stanley 19th Annual Global Healthcare Conference on Thursday, September 9, 2021 at 4:15 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at A replay of the webcast will be available following the live presentation.

Yahoo | September 8, 2021

Masimo's (MASI) ORi Favored by New Study For ICU Patients' ETI

Masimo's (MASI) ORi is expected to provide early warnings of impending hypoxemia during the ETI procedure, thus aiding in averting any adverse incident.

Yahoo | September 7, 2021

New Study Investigates the Ability of Masimo ORi to Provide Early Warning of Hypoxemia During Endotracheal Intubation in ICU Patients

Researchers Found That Use of ORi May Facilitate "Preventive Action" Against Hypoxemia Masimo (NASDAQ: MASI) announced today the findings of a prospective, blinded observational study published in

FinanzNachrichten | September 6, 2021

Masimo : Researchers Find Use Of ORi May Facilitate ''Preventive Action'' Against Hypoxemia

(RTTNews) - Masimo (MASI) said researchers concluded that the time between decrease in ORi and subsequent decrease in oxygen saturation or SpO2 "may allow preventive action," and that a higher ORi value during preoxygenation was "independently protective against hypoxemia". The company noted that Dr. Jean-Baptiste Lascarrou and colleagues at

Business Insider Markets | September 6, 2021

Masimo (MASI) Ties Up to Educate on Prescription Opioid Overuse

Masimo (MASI) partners with Penington Institute to increase awareness on overdose from prescription opioids.

Yahoo | September 6, 2021

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8055 seconds.